Pet Safety / Compounds / Amitriptyline

Is Amitriptyline safe for dogs and cats?

Moderate risk for pets

Amitriptyline is used off-label in dogs for chronic pain, behavioral disorders (separation anxiety, obsessive behaviors), and feline idiopathic cystitis in cats (though this entry covers dogs); it is also used in veterinary medicine for neuropathic pain management. Veterinary dosing (dogs): 1–2 mg/kg once or twice daily for behavioral conditions; 0.5–1 mg/kg for neuropathic pain. Toxic dose: ASPCA APCC data indicate signs at approximately 5–15 mg/kg in dogs; serious cardiac toxicity at >25 mg/kg. Signs: anticholinergic (tachycardia, urinary retention, dry mucous membranes, ileus), CNS depression or stimulation, tremors; cardiac arrhythmias (QRS widening, ventricular arrhythmias) at higher doses. Cardiac risk: the sodium channel blocking property is the most dangerous aspect — dogs can develop ventricular arrhythmias requiring sodium bicarbonate treatment; ECG monitoring essential. Narrow therapeutic index: even at intended veterinary doses, individual variability means some dogs may show toxicity signs; periodic monitoring warranted. Comparison to newer antidepressants: amitriptyline is more dangerous per mg than SSRIs in dogs; most veterinary behaviorists now prefer SSRIs and SNRIs; amitriptyline use in behavioral medicine is declining.

What is amitriptyline?

The IUPAC name is N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine.

Also known as: N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine, Amitriptylin, Seroten, Damitriptyline.

IUPAC name
N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine
CAS number
50-48-6
Molecular formula
C20H23N
Molecular weight
277.4 g/mol
SMILES
CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
PubChem CID
2160

Risk for dogs

Moderate risk

Amitriptyline is used off-label in dogs for chronic pain, behavioral disorders (separation anxiety, obsessive behaviors), and feline idiopathic cystitis in cats (though this entry covers dogs); it is also used in veterinary medicine for neuropathic pain management. Veterinary dosing (dogs): 1–2 mg/kg once or twice daily for behavioral conditions; 0.5–1 mg/kg for neuropathic pain. Toxic dose: ASPCA APCC data indicate signs at approximately 5–15 mg/kg in dogs; serious cardiac toxicity at >25 mg/kg. Signs: anticholinergic (tachycardia, urinary retention, dry mucous membranes, ileus), CNS depression or stimulation, tremors; cardiac arrhythmias (QRS widening, ventricular arrhythmias) at higher doses. Cardiac risk: the sodium channel blocking property is the most dangerous aspect — dogs can develop ventricular arrhythmias requiring sodium bicarbonate treatment; ECG monitoring essential. Narrow therapeutic index: even at intended veterinary doses, individual variability means some dogs may show toxicity signs; periodic monitoring warranted. Comparison to newer antidepressants: amitriptyline is more dangerous per mg than SSRIs in dogs; most veterinary behaviorists now prefer SSRIs and SNRIs; amitriptyline use in behavioral medicine is declining.

Regulatory consensus

2 regulatory and scientific bodies have classified Amitriptyline. The classifications differ — that's the data.

AgencyYearClassificationNotes
FDAApproved for depressionFDA-approved indication, though now predominantly used off-label for pain, migraine prophylaxis, and insomnia
American Geriatrics SocietyStrongly avoid in adults ≥65 yearsBeers Criteria recommendation due to anticholinergic burden

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where pets encounter amitriptyline

  • Industrial FacilitiesManufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational EnvironmentsFactories, Warehouses, Transportation vehicles

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Amitriptyline:

  • Therapeutic alternatives (consult prescriber)
    Trade-offs: Drug-specific. Cannot substitute without medical guidance.
    Relative cost: 1.2-2×

Frequently asked questions

Is amitriptyline safe for pets?

Amitriptyline is used off-label in dogs for chronic pain, behavioral disorders (separation anxiety, obsessive behaviors), and feline idiopathic cystitis in cats (though this entry covers dogs); it is also used in veterinary medicine for neuropathic pain management. Veterinary dosing (dogs): 1–2 mg/kg once or twice daily for behavioral conditions; 0.5–1 mg/kg for neuropathic pain. Toxic dose: ASPCA APCC data indicate signs at approximately 5–15 mg/kg in dogs; serious cardiac toxicity at >25 mg/kg. Signs: anticholinergic (tachycardia, urinary retention, dry mucous membranes, ileus), CNS depression or stimulation, tremors; cardiac arrhythmias (QRS widening, ventricular arrhythmias) at higher doses. Cardiac risk: the sodium channel blocking property is the most dangerous aspect — dogs can develop ventricular arrhythmias requiring sodium bicarbonate treatment; ECG monitoring essential. Narrow therapeutic index: even at intended veterinary doses, individual variability means some dogs may show toxicity signs; periodic monitoring warranted. Comparison to newer antidepressants: amitriptyline is more dangerous per mg than SSRIs in dogs; most veterinary behaviorists now prefer SSRIs and SNRIs; amitriptyline use in behavioral medicine is declining.

What products contain amitriptyline?

Amitriptyline appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments).

See Amitriptyline in the pets app

Look up products containing amitriptyline, compare to alternatives, and explore the full data record.

Open in pets View raw API data

Sources (2)

  1. FDA Prescribing Information: Amitriptyline (Elavil) — depression; TCA; QRS widening; sodium bicarbonate antidote; anticholinergic; Beers Criteria avoid ≥65yr; pain/migraine off-label; pediatric enuresis; narrow therapeutic index; CYP2D6 polymorphism (2023) (2023) — regulatory
  2. ASPCA Animal Poison Control Center: Tricyclic Antidepressant Toxicosis in Dogs — sodium channel blockade; cardiac arrhythmias; ECG monitoring; sodium bicarbonate treatment; anticholinergic toxidrome; toxic dose thresholds; comparison to SSRI toxicity (2023) (2023) — veterinary

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →